Intralesional injection of OK-432 for vision-threatening orbital lymphangioma

Graefe's Archive for Clinical and Experimental Ophthalmology

Volumn 245, Issue 7, 2006, Pages 1031-1035

  Yoon, Jin Sook ^a   Choi, Jung Bum ^b   Kim, Sung Joo ^c   Lee, Sang Yeul ^a,d  

^a Yonsei University College of Medicine   (South Korea)

^b Siloan Eye Hospital   (South Korea)

^c Konyang University   (South Korea)

^d Yonsei University College of Medicine   (South Korea)

Author keywords

Adverse effect; Lymphangioma; OK 432

Indexed keywords

ANTINEOPLASTIC AGENT; PICIBANIL;

ARTICLE; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; FEMALE; HUMAN; INFANT; INTRALESIONAL DRUG ADMINISTRATION; LYMPHANGIOMA; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; ORBIT TUMOR; PATHOLOGY; PRESCHOOL CHILD; RETREATMENT;

ANTINEOPLASTIC AGENTS; CHILD, PRESCHOOL; FEMALE; HUMANS; INFANT; INJECTIONS, INTRALESIONAL; LYMPHANGIOMA; MAGNETIC RESONANCE IMAGING; MALE; ORBITAL NEOPLASMS; PICIBANIL; RETREATMENT; TOMOGRAPHY, X-RAY COMPUTED;

EID: 35748944587     PISSN: 0721832X     EISSN: 1435702X     Source Type: Journal    
DOI: 10.1007/s00417-006-0510-4     Document Type: Article

References (15)

1. Boulos PR, Harissi-Dagher M, Kavalec C, Hardy I, Codere F (2005) Intralesional injection of Tisseel fibrin glue for resection of lymphangiomas and other thin-walled orbital cysts. Ophthal Plast Reconstr Surg 21:171-176
2. Gochi A, Orita K, Fuchimoto S, Tanaka N, Ogawa N (2001) The prognostic advantage of preoperative intratumoral injection of OK-432 for gastric cancer patients. Br J Cancer 84:443-451
3. Hall N, Ade-Ajayi N, Brewis C, Roebuck DJ, Kiely EM, Drake DP, Spitz L, Pierro A (2003) Is intralesional injection of OK-432 effective in the treatment of lymphangioma in children? Surgery 133:238-242
4. Harris GJ, Sakol PJ, Bonavolonta G, De Conciliis C (1990) An analysis of thirty cases of orbital lymphangioma. Pathophysiologic considerations and management recommendations. Ophthalmology 97:1583-1592
5. Katano M, Morisaki T (1998) The past, the present and future of the OK-432 therapy for patients with malignant effusions. Anticancer Res 18:3917-3925
6. Luzzato C, Midrio P, Tchaprassian Z, Guglielmi M (2000) Sclerosing treatment of lymphangiomas with OK-432. Arch Dis Child 82:316-318
7. Malhotra AD, Parikh M, Garibaldi DC, Merbs SL, Miller NR, Murphy K (2005) Resection of an orbital lymphangioma with the aid of an intralesional liquid polymer. AJNR Am J Neuroradiol 26:2630-2634
8. Ogita S, Tsuto T, Tokiwa K, Takahashi T (1987) Intracystic injection of OK-432: a new sclerosing therapy for cystic hygroma in children. Br J Surg 74:690-691
9. Ogita S, Tsuto T, Nakamura K, Deguchi E, Tokiwa K, Iwai N (1996) OK-432 threapy for lymphangioma in children: why and how does it works? J Pediatr Surg 31:477-480
10. Schwarcz RM, Ben Simon GJ, Cook T, Goldberg RA (2006) Sclerosing therapy as first line treatment for low flow vascular lesions of the orbit. Am J Ophthalmol 141:333-339
11. Sichel JY, Udassin R, Gozal D, Koplewitz BZ, Dano I, Eliashar R (2004) OK-432 therapy for cervical lymphangioma. Laryngoscope 114:1805-1809
12. Sires BS, Goins CR, Anderson RL, Holds JB (2001) Systemic corticosteroid use in orbital lymphangioma. Ophthal Plast Reconstr Surg 17:85-90
13. Suzuki Y, Obana A, Gohto Y, Miki T, Otuka H, Inoue Y (2000) Management of orbital lymphangioma using intralesional injection of OK-432. Br J Ophthalmol 84:614-617
14. Tawfik HA, Budin H, Dutton JJ (2005) Lack of Response to systemic corticosteroids in patients with lymphangioma. Ophthal Plast Reconstr Surg 21:302-305
15. Wojno TH (1999) Sotradecol (sodium tetradecyl sulfate) injection of orbital lymphangioma. Ophthal Plast Reconstr Surg 15:432-437